Quantcast
Channel: MassDevice
Browsing all 11157 articles
Browse latest View live

Image may be NSFW.
Clik here to view.

SunTech to use Masimo tech in new vital signs device

SunTech Medical said today it will work with Masimo (NSDQ:MASI) to integrate its SET pulse oximetry tech into SunTech’s CT40 next-gen spot-check vital signs device. Masimo’s SET technology is designed...

View Article


Image may be NSFW.
Clik here to view.

Centinel Spine wins Australian clearance for Stalif L implant

Centinel Spine said yesterday it won Australian Therapeutic Goods Administration clearance for its Stalif L no-profile lateral lumbar integrated interbody system. Centinel Spine touts the Stalif L as...

View Article


Image may be NSFW.
Clik here to view.

Brazilian medical device regulators moving to electronic submission system

By Stewart Eisenhart, Emergo Group ANVISA, Brazil’s medical device marker regulator, has announced plans to begin accepting electronic submissions of registration documents from manufacturers. The new...

View Article

Image may be NSFW.
Clik here to view.

Johnson & Johnson wants Pinnacle bellwethers stayed after $500m loss

A Johnson & Johnson (NYSE:JNJ) subsidiary wants a federal appeals court to hit the pause button in the multi-district litigation over its Pinnacle metal-on-metal hip implant to give it enough time...

View Article

Image may be NSFW.
Clik here to view.

Arkis BioSciences lands $3m Series A for neurosurgery tools

Arkis BioSciences said today that it raised a $3.4 million Series A round for its line of neurosurgical tools, led by Innova Memphis. Angel Capital Group, the Lighthouse Fund and private investors also...

View Article


Image may be NSFW.
Clik here to view.

Life Spine’s foot & ankle division, Centric Medical, wins FDA nod for...

Centric Medical, the foot & ankle division of Life Spine, said yesterday that it won 510(k) clearance from the FDA for its subtalar arthroereisis implant for treating flatfoot deformities. The...

View Article

Image may be NSFW.
Clik here to view.

U.K. launches study of Dune Medical’s MarginProbe breast cancer device

Dune Medical Devices said this week that the U.K.’s National Health Service is launching a study of its MarginProbe device, which is designed to spot cancerous cells on the margins of breast tumors....

View Article

Image may be NSFW.
Clik here to view.

InVivo Therapeutics touts case study in 1st spine scaffold implant

InVivo Therapeutics (NSDQ:NVIV) this week touted a case study of the 1st implantation of its spinal scaffold, a bioresorbable device designed to help treat traumatic spinal cord injuries. The study,...

View Article


Image may be NSFW.
Clik here to view.

SonoSim, GE Healthcare re-up ultrasound training deal

Ultrasound education focused SonoSim said this week it is extending a collaboration with GE Healthcare (NYSE:GE)  to cover ultrasound training and education for GE’s women’s health and urology...

View Article


Image may be NSFW.
Clik here to view.

Fresenius touts 10-year dialysis mortality reduction

Fresenius (NYSE:FMS) this week released data from an internal annual medical report, touting a 27% reduction in mortality and 22% reduction in hospitalizations amongst its permanent dialysis patients...

View Article

Image may be NSFW.
Clik here to view.

MassDevice.com +5 | The top 5 medtech stories for June 24, 2016

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...

View Article

Image may be NSFW.
Clik here to view.

Mayo Clinic study yields potential stem cell treatment for bronchopleural...

A new study from the Mayo Clinic has yielded a possible solution for treating bronchopleural fistulas using stem cells harvested from the patient’s abdominal tissue seeded into bioabsorbable meshes....

View Article

Image may be NSFW.
Clik here to view.

Helius touts 6-patient study of advanced MS cases

Helius Medical Technologies this week released the result of a 6-patient pilot study of its PoNS therapy used to treat the advanced symptoms of multiple sclerosis, touting improvements in physical,...

View Article


Image may be NSFW.
Clik here to view.

FDA: A great place for science…and for scientists on the new frontier of...

By: Robert M. Califf, M.D. As FDA Commissioner, I’m proud of our agency’s extraordinary commitment to using the best available science to support our mission to protect and promote the health of the...

View Article

Image may be NSFW.
Clik here to view.

Medtronic to put up $1.1B for HeartWare

Medtronic (NYSE:MDT) said today that it agreed to put up $1.1 billion for implantable cardiac pump maker HeartWare International (NSDQ:HTWR). The $58-per-share deal, which represents a 93.4% premium...

View Article


Image may be NSFW.
Clik here to view.

Shareholders sue TransEnterix over shelved SurgiBot

 TransEnterix (NYSE:TRXC) said today that it’s being sued by a pair of shareholders over its failure to win FDA clearance for the SurgiBot robot-assisted surgery device. Research Triangle Park,...

View Article

Image may be NSFW.
Clik here to view.

Zimmer Biomet clears U.S. anti-trust waiting period on LDR Holding acquisition

Zimmer Biomet (NYSE:ZBH) said today that its pending, $1 billion acquisition of LDR Holding (NSDQ:LDRH) cleared the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act. The...

View Article


Image may be NSFW.
Clik here to view.

Medtronic, Cochlear get in on $51m Earlens round

Earlens said today that it raised a funding round worth $51 million for the light-driven hearing aid it developed, pulling down $34 million in cash and another $17 million in a bridge financing...

View Article

Image may be NSFW.
Clik here to view.

CRO Medpace registers $150m IPO

Contract research organization Medpace last week registered for a $150 million initial public offering it plans to use to pay down some of its debt. Private equity shop Cinven paid CCMP Capital...

View Article

Image may be NSFW.
Clik here to view.

Accuray wins FDA nod for Radixact image-guided radiotherapy

Accuray (NSDQ:ARAY) said today it won FDA 510(k) clearance for its Radixact treatment delivery platform designed for image-guided radiotherapy treatments designed for cancer patients. The company said...

View Article
Browsing all 11157 articles
Browse latest View live